[{"address1": "700 Saginaw Drive", "city": "Redwood City", "state": "CA", "zip": "94063", "country": "United States", "phone": "650 481 6801", "website": "https://www.revmed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.", "fullTimeEmployees": 809, "companyOfficers": [{"maxAge": 1, "name": "Dr. Mark A. Goldsmith M.D., Ph.D.", "age": 63, "title": "CEO, President & Chairman", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 1347967, "exercisedValue": 10163472, "unexercisedValue": 51843852}, {"maxAge": 1, "name": "Mr. Jack  Anders", "age": 48, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 725633, "exercisedValue": 849639, "unexercisedValue": 2896538}, {"maxAge": 1, "name": "Ms. Margaret A. Horn J.D.", "age": 62, "title": "Chief Operating Officer", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 897933, "exercisedValue": 3021392, "unexercisedValue": 16625696}, {"maxAge": 1, "name": "Dr. Stephen M. Kelsey FRC Path., FRCP, M.D.", "age": 64, "title": "President of Research & Development", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 951933, "exercisedValue": 4257259, "unexercisedValue": 11511893}, {"maxAge": 1, "name": "Ms. Xiaolin  Wang", "age": 55, "title": "Executive Vice President of Development", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 701200, "exercisedValue": 0, "unexercisedValue": 13540803}, {"maxAge": 1, "name": "Dr. Martin D. Burke M.D., Ph.D.", "title": "Co-Founder & Chairman of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael A. Fischbach Ph.D.", "age": 44, "title": "Academic Co-Founder & Member of Scientific Advisory Board", "yearBorn": 1981, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kevan M. Shokat Ph.D.", "title": "Academic Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Walter  Reiher Ph.D.", "title": "Chief Information Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jan  Smith Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 8, "overallRisk": 7, "governanceEpochDate": 1768176000, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 98.2, "open": 98.01, "dayLow": 96.64, "dayHigh": 99.49, "regularMarketPreviousClose": 98.2, "regularMarketOpen": 98.01, "regularMarketDayLow": 96.64, "regularMarketDayHigh": 99.49, "payoutRatio": 0.0, "beta": 0.99, "forwardPE": -14.852365, "volume": 2090484, "regularMarketVolume": 2090484, "averageVolume": 3463488, "averageVolume10days": 4114430, "averageDailyVolume10Day": 4114430, "bid": 96.66, "ask": 97.19, "bidSize": 3, "askSize": 2, "marketCap": 18742353920, "fiftyTwoWeekLow": 29.17, "fiftyTwoWeekHigh": 124.49, "allTimeHigh": 124.49, "allTimeLow": 14.08, "fiftyDayAverage": 88.921, "twoHundredDayAverage": 54.381577, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 17225818112, "profitMargins": 0.0, "floatShares": 173962693, "sharesOutstanding": 193319805, "sharesShort": 14216021, "sharesShortPriorMonth": 15070669, "sharesShortPreviousMonthDate": 1765756800, "dateShortInterest": 1768435200, "sharesPercentSharesOut": 0.0735, "heldPercentInsiders": 0.01868, "heldPercentInstitutions": 1.0396199, "shortRatio": 3.06, "shortPercentOfFloat": 0.078099996, "impliedSharesOutstanding": 193319805, "bookValue": 8.418, "priceToBook": 11.516987, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -960977984, "trailingEps": -5.19, "forwardEps": -6.52758, "enterpriseToEbitda": -16.727, "52WeekChange": 1.3006644, "SandP52WeekChange": 0.1575526, "quoteType": "EQUITY", "currentPrice": 96.95, "targetHighPrice": 170.0, "targetLowPrice": 73.0, "targetMeanPrice": 112.52632, "targetMedianPrice": 100.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 19, "totalCash": 1931507968, "totalCashPerShare": 9.991, "ebitda": -1029836992, "totalDebt": 414969984, "quickRatio": 7.864, "currentRatio": 8.051, "debtToEquity": 25.986, "returnOnAssets": -0.32287, "returnOnEquity": -0.6076, "grossProfits": -880484992, "freeCashflow": -438248512, "operatingCashflow": -761793024, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RVMD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1581604200000, "postMarketChangePercent": 0.9798913, "postMarketPrice": 97.9, "postMarketChange": 0.9500046, "regularMarketChange": -1.25, "regularMarketDayRange": "96.64 - 99.49", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 3463488, "fiftyTwoWeekLowChange": 67.78, "fiftyTwoWeekLowChangePercent": 2.32362, "fiftyTwoWeekRange": "29.17 - 124.49", "fiftyTwoWeekHighChange": -27.54, "fiftyTwoWeekHighChangePercent": -0.2212226, "fiftyTwoWeekChangePercent": 130.06644, "earningsTimestamp": 1762376400, "earningsTimestampStart": 1762376400, "earningsTimestampEnd": 1762376400, "earningsCallTimestampStart": 1762378200, "earningsCallTimestampEnd": 1762378200, "isEarningsDateEstimate": false, "marketState": "CLOSED", "epsTrailingTwelveMonths": -5.19, "epsForward": -6.52758, "epsCurrentYear": -5.5403, "priceEpsCurrentYear": -17.499052, "fiftyDayAverageChange": 8.028999, "fiftyDayAverageChangePercent": 0.09029362, "twoHundredDayAverageChange": 42.56842, "twoHundredDayAverageChangePercent": 0.78277284, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "shortName": "Revolution Medicines, Inc.", "longName": "Revolution Medicines, Inc.", "exchange": "NMS", "messageBoardId": "finmb_283775412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "postMarketTime": 1769820979, "regularMarketTime": 1769806800, "regularMarketChangePercent": -1.2729125, "regularMarketPrice": 96.95, "displayName": "Revolution Medicines", "trailingPegRatio": null, "__fetch_time": "2026-01-31"}]